Topoisomerase 2β mutation impairs early B-cell development
- 4 March 2020
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 135 (17), 1497-1501
- https://doi.org/10.1182/blood.2019003299
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Roles of eukaryotic topoisomerases in transcription, replication and genomic stabilityNature Reviews Molecular Cell Biology, 2016
- Analysis of protein-coding genetic variation in 60,706 humansNature, 2016
- Topoisomerase AssaysCurrent Protocols in Pharmacology, 2012
- Primary B Cell Immunodeficiencies: Comparisons and ContrastsAnnual Review of Immunology, 2009
- Structural basis for gate-DNA recognition and bending by type IIA topoisomerasesNature, 2007
- Autosomal dominant B-cell immunodeficiency, distal limb anomalies and urogenital malformations (BILU syndrome) - report of a second familyClinical Genetics, 2004
- B cell immunodeficiency, distal limb abnormalities, and urogenital malformations in a three generation family: a novel autosomal dominant syndrome?Journal of Medical Genetics, 2001
- Characterization of DNA Topoisomerase IIα/β Heterodimers in HeLa CellsBiochemistry, 1998
- Toprim--a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteinsNucleic Acids Research, 1998
- Active heterodimers are formed from human DNA topoisomerase II alpha and II beta isoforms.Proceedings of the National Academy of Sciences, 1996